The Short Form-36: Pre- Versus Post-Surgical Administration in Cardiac Surgery Patients
NCT ID: NCT00226265
Last Updated: 2017-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
1999-01-31
2007-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life After Open Heart Surgery in Older Patients
NCT00248898
Autonomic State, Cardiovascular Control and Outcomes in Coronary Surgery
NCT03169608
Preparation of Patients for Cardiac Surgery
NCT00906646
Pharmacokinetics of Cefuroxime in Cardiac Surgery With Cardiopulmonary Bypass
NCT01228825
Improving Outcomes and Quality of Life After CABG
NCT00256620
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Are English speaking
* Able to give consent
* Undergoing cardiac surgery including (but not limited to):
* Aortic valve replacement (AVR)
* Mitral valve replacement (MVR)
* Tricuspid valve replacement (TVR)
* Coronary artery bypass graft (CABG).
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Weill Medical College of Cornell University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mary E. Charlson, MD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mary E Charlson, MD
Role: PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The New York Presbyterian Hospital-Weill Medical Center
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1203-069
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.